The resistance of cyclin D1−/−/MMTV-ErbB2 mice to ErbB2 driven mammary tumors is thought to be dependent on a complete absence of PI mammary cells in cyclin D1-null mice [14]. This evidence concerns the gene ERBB2 and breast cancer.